Selective T Cell Costimulation Modulator [EPC]

93106 reported adverse events

Drugs of this class: ABATACEPT

These side effects are most commonly reported by patients taking drugs of the Selective T Cell Costimulation Modulator [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 30965
1 RHEUMATOID ARTHRITIS 16387
2 PAIN 13196
3 ARTHRALGIA 10562
4 JOINT SWELLING 10181
5 CONTRAINDICATED PRODUCT ADMINISTERED 9972
6 FATIGUE 8970
7 DRUG INTOLERANCE 8928
8 RASH 8101
9 ARTHROPATHY 7126
See all common reactions for Selective T Cell Costimulation Modulator [EPC]

Drugs of the Selective T Cell Costimulation Modulator [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 270 0.9278
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2159 0.8358
2 SWOLLEN JOINT COUNT INCREASED 427 0.8356
3 RED BLOOD CELL SEDIMENTATION RATE 160 0.8040
4 RHEUMATOID FACTOR NEGATIVE 132 0.7904
5 PEMPHIGUS 4526 0.7669
6 RHEUMATOID FACTOR POSITIVE 1916 0.7458
7 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 61 0.7011
8 RHEUMATIC FEVER 525 0.6783
9 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1206 0.6652
See all enriched reactions for Selective T Cell Costimulation Modulator [EPC]